文献速递自身炎症与 IgG4 相关病其他结缔组织病

九种单基因自身炎症性疾病的系统评估揭示与过敏相关特征的共同及疾病特异性关联

Systematic evaluation of nine monogenic autoinflammatory diseases reveals common and disease-specific correlations with allergy-associated features.
PubMed 文献 · Ann Rheum Dis · 2021-02-22

该横断面研究评估了425例九种单基因自身炎症性疾病(AID)患者的临床与免疫表型,发现CAPS以2型免疫增强为特征,而FMF和CANDLE与2型反应降低相关;DADA2虽2型反应降低但医生诊断的过敏症比例高,提示NLRP3驱动的自身炎症可能促进2型免疫,而部分AID可表现为类似过敏性疾病的临床表型。

要点

  • CAPS患者2型免疫标志物升高且Th2细胞扩增,FMF和CANDLE则2型反应降低。
  • DADA2患者2型反应降低但医生诊断过敏症比例高,可能模拟过敏性疾病。
  • HA20患者Th9细胞扩增,TRAPS和HIDS患者Th2细胞扩增。

核心结论

  • CAPS以增强的2型免疫特征为特点,而FMF和CANDLE与降低的2型反应相关。
  • DADA2与降低的2型反应相关但医生诊断的过敏症比例高,部分AID临床表型可能模拟过敏性疾病。

研究设计与样本

  • 横断面研究,采用问卷和病历回顾评估425例九种单基因自身炎症性疾病患者的临床数据。
  • 比较数据来自公共数据库,并刺激55例患者的外周血单个核细胞评估CD4+细胞因子产生。

主要发现

  • CAPS患者2型免疫的临床实验室特征升高,而大多数AID(尤其是DADA2)降低。
  • 医生诊断的过敏性疾病在多种AID中普遍存在,包括CAPS和DADA2。
  • Th2细胞在CAPS、TRAPS和HIDS中扩增,Th9细胞在HA20中扩增。

关键数值与推荐

  • CAPS以增强的2型免疫特征为特点,FMF和CANDLE与降低的2型反应相关。
  • DADA2与降低的2型反应相关但医生诊断的过敏症比例高。

临床怎么用

  • 对于CAPS、DADA2等AID患者,需关注过敏相关临床表型,避免将AID表现误诊为单纯过敏性疾病。
  • 评估AID患者时应考虑2型免疫特征,CAPS患者可能受益于针对2型免疫的评估。

局限性

  • 需要进一步研究确定自身炎症对过敏临床和免疫表型的贡献,以改善AID患者的治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Monogenic autoinflammatory diseases (AID) are caused by mutations in innate immune genes. The effects of these mutations on allergic inflammation are unknown. OBJECTIVES: We investigated allergic, immunological and clinical phenotypes in FMF (familial Mediterranean fever), CAPS (cryopyrin-associated periodic syndrome), TRAPS (tumour necrosis factor receptor-associated periodic syndrome), HIDS (hyper-IgD syndrome), PAPA (pyogenic arthritis, pyoderma gangrenosum and acne), DADA2 (deficiency of adenosine deaminase 2), HA20 (haploinsufficiency of A20), CANDLE (chronic atypical neutrophilic dermatosis, lipodystrophy, elevated temperature) and SAVI (STING-associated vasculopathy of infancy). METHODS: In this cross-sectional study, clinical data were assessed in 425 patients with AID using questionnaires and chart reviews. Comparator data were obtained from public databases. Peripheral blood mononuclear cells obtained from 55 patients were stimulated and CD4+ cytokine production assessed. RESULTS: Clinical laboratory features of Type 2 immunity were elevated in CAPS but reduced in most AID, particularly DADA2. Physician-diagnosed allergic diseases were prevalent in multiple AID, including CAPS and DADA2. T helper 2 (Th2) cells were expanded in CAPS, TRAPS and HIDS; Th9 cells were expanded in HA20. CONCLUSIONS: CAPS is characterised by an enhanced Type 2 signature, whereas FMF and CANDLE are associated with reduced Type 2 responses. DADA2 is associated with reduced Type 2 responses but a high rate of physician-diagnosed allergy. Therefore, NLRP3-driven autoinflammation may promote Type 2 immunity, whereas AID like DADA2 may manifest clinical phenotypes that masquerade as allergic disorders. Further investigations are needed to determine the contribution of autoinflammation to allergic clinical and immunological phenotypes, to improve the treatment of patients with AID.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Schwartz DM, Kitakule MM, Dizon BL, et al. Systematic evaluation of nine monogenic autoinflammatory diseases reveals common and disease-specific correlations with allergy-associated features. Ann Rheum Dis. 2021. PMID: 33619160. doi:10.1136/annrheumdis-2020-219137

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。